Raj Chari Selected Research

Raj Chari Research Topics

Disease

20	Neoplasms (Cancer) 12/2021 - 02/2008
7	Lung Neoplasms (Lung Cancer) 10/2011 - 08/2007
2	Melanoma (Melanoma, Malignant) 01/2021 - 01/2021
2	Colorectal Neoplasms (Colorectal Cancer) 10/2020 - 01/2020
2	Carcinogenesis 04/2012 - 10/2011
2	Adenocarcinoma 01/2012 - 07/2010
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2012 - 07/2010
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2021
1	Dystonia (Limb Dystonia) 01/2021
1	Dystonia Musculorum Deformans (Torsion Dystonia) 01/2021
1	Experimental Melanoma 01/2021
1	Movement Disorders (Movement Disorder) 01/2021
1	Ovarian Neoplasms (Ovarian Cancer) 01/2021
1	Glioma (Gliomas) 01/2020
1	Mesothelioma 01/2020
1	Mosquito-Borne Diseases 12/2015
1	West Nile Fever 12/2015
1	Communicable Diseases (Infectious Diseases) 12/2015
1	Infections 12/2015
1	Chronic Obstructive Pulmonary Disease (COPD) 05/2014
1	Hypertension (High Blood Pressure) 01/2013
1	Pheochromocytoma 01/2013
1	Adenocarcinoma of Lung 01/2012
1	Mouth Neoplasms (Oral Cancer) 11/2011
1	Carcinoma in Situ 09/2011
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 09/2011
1	Leukemia 01/2011
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2011
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2010
1	Breast Neoplasms (Breast Cancer) 05/2010
1	Uterine Cervical Dysplasia 02/2008
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 02/2008
1	Celiac Disease (Celiac Sprue) 05/2007

Drug/Important Bio-Agent (IBA)

9	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2009
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 09/2011
4	MicroRNAs (MicroRNA)IBA 11/2011 - 03/2010
3	Biological ProductsIBA 01/2021 - 02/2008
2	Proteasome Endopeptidase Complex (Proteasome)IBA 12/2021 - 01/2020
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2021 - 01/2020
2	SmokeIBA 05/2014 - 08/2007
2	Biomarkers (Surrogate Marker)IBA 04/2012 - 02/2010
1	physachenolide CIBA 01/2021
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2021
1	Cisplatin (Platino)FDA LinkGeneric 01/2021
1	ElementsIBA 01/2021
1	LigandsIBA 01/2021
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2021
1	Poly I-CIBA 01/2021
1	PolynucleotidesIBA 01/2021
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2021
1	Long Noncoding RNAIBA 10/2020
1	olaparibIBA 01/2020
1	GlutaminaseIBA 01/2020
1	alpha-hydroxyglutarateIBA 01/2020
1	talazoparibIBA 01/2020
1	Aspartate-Ammonia Ligase (Asparagine Synthetase)IBA 01/2020
1	MethyltransferasesIBA 01/2020
1	Deubiquitinating EnzymesIBA 01/2020
1	Glutamine (L-Glutamine)FDA Link 01/2020
1	Poly Adenosine Diphosphate RiboseIBA 01/2020
1	Temozolomide (Temodar)FDA LinkGeneric 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	Transcription Factors (Transcription Factor)IBA 11/2019
1	VaccinesIBA 12/2015
1	AntibodiesIBA 12/2015
1	Neutralizing AntibodiesIBA 12/2015
1	NF-E2-Related Factor 2IBA 05/2014
1	Hormones (Hormone)IBA 01/2013
1	Epinephrine (Adrenaline)FDA LinkGeneric 01/2013
1	Indicators and Reagents (Reagents)IBA 01/2013
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2013
1	Chromogranin AIBA 01/2013
1	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2013
1	Nerve Growth Factor (NGF)IBA 01/2013
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2013
1	Messenger RNA (mRNA)IBA 10/2011
1	TNF Receptor-Associated Factor 6 (TRAF6)IBA 10/2011
1	NF-kappa B (NF-kB)IBA 09/2011
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 09/2011
1	I-kappa B KinaseIBA 09/2011
1	RNA (Ribonucleic Acid)IBA 01/2011
1	Pharmaceutical PreparationsIBA 01/2011
1	Histones (Histone)IBA 03/2010
1	XenobioticsIBA 02/2010
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 04/2008
1	beta CateninIBA 04/2008
1	ChromatinIBA 02/2008
1	HLA-DQB1 antigen (HLA DQB1)IBA 05/2007

Therapy/Procedure

4	Therapeutics 01/2020 - 07/2010
2	Immunotherapy 01/2021 - 01/2021
2	Drug Therapy (Chemotherapy) 01/2012 - 01/2011
1	Neoadjuvant Therapy 04/2012